Functional Movement DisorderNCT07372755
Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders
An observational study of Functional Movement Disorder, run by Western University, Canada at 1 site in Canada.
Trial summary
People with FMD may experience symptoms such as tremor, jerks, spasms, or difficulty walking. These symptoms are not caused by damage to the brain or nerves. Instead, they happen because the brain is not sending or processing signals in the usual way. Read more about this study
- Who is it for?
- Ages 18 to 18 years
- Conditions the study is for
- Functional Movement Disorder
- How many people
- 10 participants
- Where
- 1 siteCanada
- Study dates
- 1 Feb 2026to 1 Jun 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 18 years
- All sexes
- No healthy volunteers
- Adult
Study population: Functional Movement Disorder Clinic
Who may be able to join
- Age ≥18
- Diagnosed with a functional movement disorder
- Own a smartphone
- Ability to read and understand English
- Ability to provide informed consent
Who cannot join
- Acute psychiatric crisis
- Limitations that make it impossible to use a smartphone app
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site
University Hospital
London, N6A5A5
Aditya Murgai, MBBS, 5196633121, murgai03@gmail.com
About this study
People with FMD may experience symptoms such as tremor, jerks, spasms, or difficulty walking. These symptoms are not caused by damage to the brain or nerves. Instead, they happen because the brain is not sending or processing signals in the usual way. Symptoms can change from day to day, and stress, emotions, or certain situations may make them better or worse.
Right now, patients are often asked to remember how their symptoms have been since their last clinic visit or to write things down in a notebook. This can be hard to do and may not give an accurate picture of what is happening. Because of this, doctors and patients may miss important patterns or triggers, and it can be harder to know which coping strategies are helpful.
To improve this, our team has created a mobile app that allows people with FMD to easily record their symptoms, stress level, and mood, in real time. The app also includes simple self-help tools that may support symptom management. Before using this app more widely, we want to find out (1) whether patients can use it as intended and (2) whether they find it easy and helpful to use. This study will help us understand if the app is practical for use in an FMD clinic and how it could be improved.
Read the detailed description
Functional movement disorders (FMD) can cause symptoms such as tremor, jerking, or walking difficulties. These symptoms are not due to structural damage in the brain or nerves but relate to how the brain is functioning. Symptoms often vary over time and may be affected by stress, emotions, and everyday situations, which can be hard to track accurately between clinic visits.
This study will evaluate the feasibility and usability of a mobile application designed to help people with FMD record symptom flares, stress levels, and possible triggers, and access simple self-help tools. The app also produces summary reports that can be reviewed during clinic visits.
Ten adults with FMD will use the app for six weeks. Participants on the first visit will be given brief training about the app. Follow-up visits will be every two weeks to review app summaries and address technical issues. At week 6, participants will complete a short usability questionnaire and a brief interview about their experience.
The study's main goal is to determine whether participants can and will use the app as intended and whether they find it acceptable and easy to use
We invite you to take part in a research study looking at a new mobile phone app designed for people with Functional Movement Disorders (FMD). Taking part is completely voluntary.
- Conditions
- Functional Movement Disorder
- Keywords
- functional movement disorder, mobile app
- Medical subject headings
- Conversion Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Functional Movement Disorder | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility: Can patients use the app as intended for 6 weeks?
Can patients use the app as intended for 6 weeks?
Measured: 6 weeks
Acceptability and Usability
Do patients find the app acceptable and easy to use?
Measured: 6 weeks
Secondary outcomes (1)
Clinical Utility
Do app summaries feel clinically useful during visits?
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jan 2026
- Study start1 Feb 2026 (estimated)
- Primary completion1 Feb 2028 (estimated)
- Study completion1 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Functional Movement DisorderStudies of the same condition, open and under way.
- More trials run by Western University, CanadaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Western University, Canada
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aditya Murgai, Western University, Canada
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07372755
- Sponsor's protocol ID
- 128351
- Status last verified
- Jan 2026
- First submitted
- 19 Jan 2026
- Last updated
- 28 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: At this time, IPD will not be shared due to confidentiality concerns.
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders
- ClinicalTrials.gov ID
- NCT07372755
- Acronym / sponsor ID
- 128351
- Conditions
- Functional Movement Disorder
- Keywords
- functional movement disorder, mobile app
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Western University, CanadaUniversity, hospital or other
- Study start
- 1 Feb 2026 (estimated)
- Primary completion
- 1 Feb 2028 (estimated)
- Study completion
- 1 Jun 2028 (estimated)
- First posted
- 28 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
People with FMD may experience symptoms such as tremor, jerks, spasms, or difficulty walking. These symptoms are not caused by damage to the brain or nerves. Instead, they happen because the brain is not sending or processing signals in the usual way. Symptoms can change from day to day, and stress, emotions, or certain situations may make them better or worse.
Right now, patients are often asked to remember how their symptoms have been since their last clinic visit or to write things down in a notebook. This can be hard to do and may not give an accurate picture of what is happening. Because of this, doctors and patients may miss important patterns or triggers, and it can be harder to know which coping strategies are helpful.
To improve this, our team has created a mobile app that allows people with FMD to easily record their symptoms, stress level, and mood, in real time. The app also includes simple self-help tools that may support symptom management. Before using this app more widely, we want to find out (1) whether patients can use it as intended and (2) whether they find it easy and helpful to use. This study will help us understand if the app is practical for use in an FMD clinic and how it could be improved.
Detailed description
Functional movement disorders (FMD) can cause symptoms such as tremor, jerking, or walking difficulties. These symptoms are not due to structural damage in the brain or nerves but relate to how the brain is functioning. Symptoms often vary over time and may be affected by stress, emotions, and everyday situations, which can be hard to track accurately between clinic visits.
This study will evaluate the feasibility and usability of a mobile application designed to help people with FMD record symptom flares, stress levels, and possible triggers, and access simple self-help tools. The app also produces summary reports that can be reviewed during clinic visits.
Ten adults with FMD will use the app for six weeks. Participants on the first visit will be given brief training about the app. Follow-up visits will be every two weeks to review app summaries and address technical issues. At week 6, participants will complete a short usability questionnaire and a brief interview about their experience.
The study's main goal is to determine whether participants can and will use the app as intended and whether they find it acceptable and easy to use
We invite you to take part in a research study looking at a new mobile phone app designed for people with Functional Movement Disorders (FMD). Taking part is completely voluntary.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Functional Movement Disorder | – | – |
Who may qualify
- Ages
- 18 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Functional Movement Disorder Clinic
Key inclusion criteria (5 listed)
- Age ≥18
- Diagnosed with a functional movement disorder
- Own a smartphone
- Ability to read and understand English
- Ability to provide informed consent
Key exclusion criteria (2 listed)
- Acute psychiatric crisis
- Limitations that make it impossible to use a smartphone app
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Feasibility: Can patients use the app as intended for 6 weeks?
Time frame: 6 weeks
Can patients use the app as intended for 6 weeks?
Acceptability and Usability
Time frame: 6 weeks
Do patients find the app acceptable and easy to use?
1 secondary outcome
Clinical Utility
Time frame: 6 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2026.
- Individual participant dataSharing planned: No. At this time, IPD will not be shared due to confidentiality concerns.
Related trials for Functional Movement Disorder
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Not yet recruiting
The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease
Parkinson Disease
RecruitingObservational study
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
Parkinson Disease
Recruiting
Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia
Dystonia Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Functional Movement Disorder, run by Western University, Canada at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aditya Murgai, MBBS MD DM (15196633121, aditya.murgai@lhsc.on.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility: Can patients use the app as intended for 6 weeks? (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.